NRG
ELV icon

Nemes Rush Group’s Elevance Health ELV Stock Holding History

Nemes Rush Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.1K Buy
14
+10
+250% +$3.29K ﹤0.01% 657
2025
Q4 		$1.4K Buy
+4
New +$1.35K ﹤0.01% 771
2025
Q3 		– Sell
-29
Closed -$11.3K – 695
2025
Q2 		$11.3K Hold
29
– – ﹤0.01% 462
2025
Q1 		$12.6K Sell
29
-10
-26% -$4.01K ﹤0.01% 445
2024
Q4 		$14.4K Buy
39
+10
+34% +$4.18K ﹤0.01% 430
2024
Q3 		$15K Hold
29
– – ﹤0.01% 369
2024
Q2 		$15.7K Hold
29
– – ﹤0.01% 366
2024
Q1 		$15K Sell
29
-18
-38% -$8.95K ﹤0.01% 406
2023
Q4 		$22.2K Hold
47
– – ﹤0.01% 338
2023
Q3 		$20.5K Buy
47
+18
+62% +$8.16K ﹤0.01% 337
2023
Q2 		$12.9K Buy
+29
New +$13.4K ﹤0.01% 402

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Nemes Rush Group's ELV Position: Q1 2026 in Review

Nemes Rush Group increased its Elevance Health (ELV) stake by 250% in Q1 2026, buying an estimated $3.29K and bringing the position to 14 shares worth $4.1K. The position accounts for ﹤0.01% of the portfolio, ranked #657.

Nemes Rush Group first reported a position in ELV in Q2 2023 and has held it in 11 quarters since. The position peaked at $22.2K in Q4 2023. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Nemes Rush Group held 14 shares of Elevance Health worth $4.1K as of Q1 2026.
  • Nemes Rush Group bought 10 Elevance Health shares in Q1 2026, an estimated $3.29K.
  • Elevance Health made up ﹤0.01% of Nemes Rush Group's portfolio in Q1 2026, its #657 holding.
  • Nemes Rush Group first reported a position in Elevance Health in Q2 2023 and has held it in 11 quarters since.
  • Nemes Rush Group's Elevance Health position peaked at $22.2K in Q4 2023.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Nemes Rush Group's 13F filing for Q1 2026, filed 21 Apr 2026.